Turkey Prepares For Great Leap Forward In IPR
Turkey’s government has prepared a draft of a new IPR law, which has already passed through parliamentary commissions and is now awaiting a final vote in the General Assembly. Although generally welcomed by the pharmaceutical industry, the draft has also revealed some divisions between multinationals and local companies.
You may also be interested in...
Unpaid hospital debts have been hitting the Turkish medical sector for some time, but a government plan to repay less than the full amount owed has angered industry.
Turkey’s efforts to control rising rates of COVID-19 are compromising the ability of hospitals to pay their debts to medtech and pharmaceutical companies. The government has devised a payments plan, but there is catch.
The Turkish medtech industry’s ongoing hospital payments problems appeared likely to come back onto the government’s agenda, with the national economy recovering somewhat in late 2019. But COVID-19 dashed those hopes.